2022 International Autoimmune Hepatitis Group non-response criteria in autoimmune hepatitis: A too early endpoint?
- PMID: 35716845
- DOI: 10.1016/j.jhep.2022.06.007
2022 International Autoimmune Hepatitis Group non-response criteria in autoimmune hepatitis: A too early endpoint?
Conflict of interest statement
Conflict of interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment in
-
Reply to: "Correspondence on 'Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group'": Defining endpoints that guide treatment in autoimmune hepatitis.J Hepatol. 2022 Nov;77(5):1464-1466. doi: 10.1016/j.jhep.2022.07.025. Epub 2022 Aug 17. J Hepatol. 2022. PMID: 35985543 No abstract available.
-
2022 International autoimmune hepatitis group non-response criteria in autoimmune hepatitis: Quick vs. slow responders.J Hepatol. 2023 Mar;78(3):e113-e114. doi: 10.1016/j.jhep.2022.09.026. Epub 2022 Oct 13. J Hepatol. 2023. PMID: 36243178 No abstract available.
Comment on
-
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group.J Hepatol. 2022 Apr;76(4):841-849. doi: 10.1016/j.jhep.2021.12.041. Epub 2022 Jan 20. J Hepatol. 2022. PMID: 35066089
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources